T. Sakata

发表

Sodium Salicylate Enhances Expression of Tissue Factor ( TF ) in HumanAdherent Monocytes and in Whole Blood

T. Miyata, H. Kato, T. Kawasaki, 2018 .

Silent cerebral infarcts in basal ganglia are advanced in congenital protein C-deficient heterozygotes with hypertension.

K. Kario, T. Miyata, S. Hoshide, 2001, American journal of hypertension.

Detection of antibodies against domain 1 of β2-glycoprotein I is key in predicting thromboembolic complications in patients with systemic lupus erythematosus.

K. Ichihara, H. Tsuneoka, J. Nojima, 2017, Thrombosis research.

Association of platelet aggregation with lipid levels in the Japanese population: the Suita study.

Y. Kokubo, T. Miyata, Mana Mitsuguro, 2011, Journal of atherosclerosis and thrombosis.

Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.

K. Kario, T. Miyata, T. Matsuo, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.

H. Naritomi, K. Minematsu, M. Yasaka, 2005, Thrombosis research.

Gender differences of disturbed hemostasis related to fasting insulin level in healthy very elderly Japanese aged > or = 75 years.

K. Kario, T. Miyata, T. Matsuo, 1995, Atherosclerosis.

Suppression of plasma-activated factor VII levels by warfarin therapy.

K. Kario, T. Miyata, H. Kato, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Protein C Osaka 10 with Aberrant Propeptide Processing: Loss of Anticoagulant Activity Due to an Amino Acid Substitution in the Protein C Precursor

T. Miyata, H. Kato, T. Sakata, 1995, Thrombosis and Haemostasis.

High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage.

K. Kario, T. Miyata, H. Kato, 2001, Atherosclerosis.

The Strong Positive Correlation between Factor VII Clotting Activity Using Bovine Thromboplastin and the Activated Factor VII Level

K. Kario, T. Miyata, H. Kato, 1995, Thrombosis and Haemostasis.

Factor VII hyperactivity and ischaemic heart disease

K. Kario, T. Miyata, T. Matsuo, 1994, The Lancet.

Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.

K. Kario, T. Miyata, H. Kato, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Factor VII in non-insulin-dependent diabetic patients with microalbuminuria

K. Kario, T. Miyata, T. Matsuo, 1993, The Lancet.

Studies on Congenital Protein C Deficiency in Japanese: Prevalence, Genetic Analysis, and Relevance to the Onset of Arterial Occlusive Diseases

K. Kario, T. Miyata, H. Kato, 2000, Seminars in thrombosis and hemostasis.

Marked Increase of Activated Factor VII in Uremic Patients

K. Kario, T. Yamada, T. Miyata, 1995, Thrombosis and Haemostasis.

Population‐based distribution of plasminogen activity and estimated prevalence and relevance to thrombotic diseases of plasminogen deficiency in Japanese: the Suita Study

T. Miyata, H. Tomoike, K. Minematsu, 2003, Journal of thrombosis and haemostasis : JTH.

von Willebrand factor‐to‐ADAMTS13 ratio increases with age in a Japanese population

Y. Kokubo, T. Miyata, K. Kokame, 2011, Journal of thrombosis and haemostasis : JTH.

Genetic Diagnosis of Dysplasminogenemia: Detection of an Ala601 -Thr Mutation in 118 out of 125 Families and Identification of a New Asp676-Asn Mutation

T. Miyata, A. Ichinose, T. Saito, 1996, Thrombosis and Haemostasis.

Usefulness of antithrombin deficiency phenotypes for risk assessment of venous thromboembolism: type I deficiency as a strong risk factor for venous thromboembolism

Y. Kokubo, T. Miyata, Y. Tsutsumi, 2010, International journal of hematology.

Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese

T. Miyata, A. Okamoto, T. Sakata, 2004, Journal of thrombosis and haemostasis : JTH.

Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication.

H. Naritomi, K. Minematsu, M. Yasaka, 2002, Thrombosis research.

Clinical significance of activated protein C resistance as a potential marker for hypercoagulable state.

K. Kario, T. Miyata, H. Kato, 1996, Thrombosis research.

Accelerated Brain Infarction in Hypertension Complicated by Hereditary Heterozygous Protein C Deficiency

S. Kazui, Y. Kuriyama, T. Sawada, 1993, Stroke.

Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers

Y. Kokubo, T. Miyata, A. Okayama, 2006, Journal of thrombosis and haemostasis : JTH.

A Case of Arterial Cerebral Thrombosis with Congenital Protein C Deficiency

S. Kazui, T. Sawada, K. Uchida, 1992 .

Increased plasma plasminogen activator inhibitor-1 levels caused by additional aspirin treatment

K. Kario, T. Sakata, 2006, Thrombosis and Haemostasis.

Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries.

K. Kario, Y. Kokubo, N. Ohkura, 2004, Atherosclerosis.

C-399T Polymorphism in the Promoter Region of Human Tissue Factor Pathway Inhibitor (TFPI) Gene Does not Change the Plasma TFPI Antigen Level and Does not Cause Venous Thrombosis

T. Miyata, H. Kato, T. Kawasaki, 1998, Thrombosis and Haemostasis.

Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies

T. Doi, C. Inoue, M. Abe, 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Xanthoangelols isolated from Angelica keiskei inhibit inflammatory-induced plasminogen activator inhibitor 1 (PAI-1) production.

G. Atsumi, N. Ohkura, J. Matsuda, 2011, BioFactors.

Analysis of 45 episodes of arterial occlusive disease in Japanese patients with congenital protein C deficiency.

K. Kario, T. Miyata, H. Kato, 1999, Thrombosis research.

Does hypertension confer a hypercoagulable state in stroke‐prone spontaneously hypertensive rats?

T. Sasaguri, T. Abumiya, H. Kato, 2000, Journal of hypertension.

Genetic analysis of protein C deficiency in nineteen Japanese families: five recurrent defects can explain half of the deficiencies.

T. Miyata, A. Shirahata, H. Kato, 1998, Thrombosis research.

Genetic Characterization of Protein C Deficiency in Japanese Subjects Using a Rapid and Nonradioactive Method for Single-Strand Conformational Polymorphism Analysis and a Model Building

T. Miyata, A. Yoshioka, H. Umeyama, 1996, Thrombosis and Haemostasis.

Prevalence of Protein C Deficiency in Patients with Cardiovascular Problems in Japan

T. Miyata, H. Kato, Y. Katayama, 1999, Thrombosis and Haemostasis.

Recurrent restenosis after percutaneous transluminal coronary angioplasty in a patient with congenital protein C deficiency and high activated factor VII level.

K. Kario, T. Miyata, H. Kato, 1996, Thrombosis research.

Six missense mutations associated with type I and type II protein C deficiency and implications obtained from molecular modelling

T. Miyata, H. Kato, H. Umeyama, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Three Missense Mutations in the Protein C Heavy Chain Causing Type I and Type II Protein C Deficiency

N. Tsushima, T. Miyata, T. Sakata, 1994, Thrombosis and Haemostasis.

Detection of two novel mutations (nt2762, exon 2, CAG to TAG, and nt2483 or 2484, exon 2, +A) in individuals with congenital type I antithrombin deficiencies.

T. Miyata, K. Nakagawa, M. Nakagawa, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Genetic Risk Factors for Deep Vein Thrombosis among Japanese: Importance of Protein S K196E Mutation

Y. Kokubo, T. Miyata, T. Sakata, 2006, International journal of hematology.

Circadian Variations in Coagulation and Fibrinolytic Factors among Four Different Strains of Mice

K. Kadota, K. Oishi, G. Atsumi, 2007, Chronobiology international.

Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin.

H. Naritomi, K. Minematsu, M. Yasaka, 2003, Thrombosis and haemostasis.

Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia.

M. Monden, T. Miyata, H. Kato, 2000, Thrombosis research.

Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis.

Yukiko Sato, S. Madoiwa, S. Honda, 2009, Thrombosis research.

Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria.

K. Kario, K. Shimada, T. Miyata, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Polymorphisms in Vitamin K—Dependent γ-Carboxylation—Related Genes Influence Interindividual Variability in Plasma Protein C and Protein s Activities in the General Population

Y. Kokubo, H. Naritomi, S. Honda, 2006, International journal of hematology.

K. Kario, T. Miyata, A. Yamamoto, 1999, Thrombosis and Haemostasis.

Is acquired activated protein C resistance a cardiovascular risk?

K. Kario, S. Kiechl, J. Willeit, 2000, Circulation.

Prevalence of protein S deficiency in the Japanese general population: The Suita Study

T. Miyata, H. Tomoike, A. Okamoto, 2004, Journal of thrombosis and haemostasis : JTH.

Age- and gender-related differences of plasma prothrombin activity levels

Y. Kokubo, T. Miyata, A. Okayama, 2007, Thrombosis and Haemostasis.

Lipid-lowering therapy corrects endothelial cell dysfunction in a short time but does not affect hypercoagulable state even after long-term use in hyperlipidemic patients.

K. Kario, U. Ikeda, T. Mitsuhashi, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency

Yukiko Sato, S. Madoiwa, S. Honda, 2007, Thrombosis and Haemostasis.

Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levels.

K. Kario, T. Sakata, 2011, Atherosclerosis.

plasma PAI-1 levels in patients with ischemic stroke. Plasma PAI-1 levels may be new markers to help protect against platelet- mediated atherothrombosis (11).

K. Kario, T. Sakata, 2011 .

Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin.

H. Naritomi, K. Minematsu, M. Yasaka, 2003, Thrombosis and haemostasis.

Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome

K. Ichihara, J. Nojima, Yukari Motoki, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Analyses of haemorheological, hematological and coagulofibrinolytic factors in normal control and patients of arteriosclerotic obliteration

N. Tsushima, K. Uchida, Y. Katayama, 1987 .

Detection of antibodies against domain 1 of β2-glycoprotein I is key in predicting thromboembolic complications in patients with systemic lupus erythematosus.

K. Ichihara, H. Tsuneoka, J. Nojima, 2017, Thrombosis research.

[Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].

Y. Katayama, T. Sakata, T. Matsuyama, 1991, Rinsho byori. The Japanese journal of clinical pathology.